PRA Health Sciences, Inc. announced the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President, Scientific and Clinical Affairs. He will lead the company's Global Center of Excellence for Decentralized Clinical Trial (DCT) Strategy. Dr. Rodriguez-Chavez's responsibilities will involve the continued growth and development of PRA's decentralized clinical trial strategy, regulatory framework creation, and clinical trial modernization. Dr. Rodriguez-Chavez has more than 32 years of experience in virology, microbiology, immunology, vaccinology and viral oncology, including basic, pre-clinical and clinical research (phase I-IV). Most recently as a Senior Officer for Clinical Research Methodologies, Regulatory Compliance, and Medical Policy Development with the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER), he led the development of guidance around decentralized clinical trials using digital health technologies.